Twist Bioscience Corp (TWST)
47.04
+0.54
(+1.16%)
USD |
NASDAQ |
May 17, 16:00
47.04
0.00 (0.00%)
After-Hours: 20:00
Twist Bioscience Cash from Financing (TTM): 0.136M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 0.136M |
December 31, 2023 | -0.167M |
September 30, 2023 | 0.911M |
June 30, 2023 | 1.709M |
March 31, 2023 | 1.059M |
December 31, 2022 | 271.15M |
September 30, 2022 | 270.53M |
June 30, 2022 | 270.87M |
March 31, 2022 | 271.42M |
December 31, 2021 | 1.25M |
September 30, 2021 | 329.18M |
June 30, 2021 | 333.18M |
Date | Value |
---|---|
March 31, 2021 | 442.01M |
December 31, 2020 | 628.60M |
September 30, 2020 | 303.73M |
June 30, 2020 | 301.09M |
March 31, 2020 | 277.31M |
December 31, 2019 | 87.64M |
September 30, 2019 | 158.58M |
June 30, 2019 | 162.23M |
March 31, 2019 | 102.78M |
December 31, 2018 | 159.16M |
September 30, 2018 | 88.82M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.167M
Minimum
Dec 2023
628.60M
Maximum
Dec 2020
205.62M
Average
270.70M
Median
Cash from Financing (TTM) Benchmarks
Tandem Diabetes Care Inc | 18.24M |
Perspective Therapeutics Inc | 167.19M |
Xtant Medical Holdings Inc | 20.30M |
Asensus Surgical Inc | 10.92M |
Catheter Precision Inc | -0.158M |